MOMC-5. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma

BACKGROUND: Medulloblastoma (MB) is the most common malignant paediatric brain tumour and a leading cause of cancer-related mortality and morbidity. Existing treatment protocols are aggressive in nature resulting in significant neurological, intellectual and physical disabilities for the children un...

Descripción completa

Detalles Bibliográficos
Autores principales: Genovesi, Laura, Millar, Amanda, Tolson, Elissa, Singleton, Matthew, Hassall, Emily, Kojic, Marija, Brighi, Caterina, Girald, Emily, Andradas, Clara, Kuchibhotla, Mani, Endersby, Raelene, Gottardo, Nicholas, Bernard, Anne, Adolphe, Christelle, Olson, James, Davis, Melissa, Wainwright, Brandon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255431/
http://dx.doi.org/10.1093/noajnl/vdab070.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255431/
http://dx.doi.org/10.1093/noajnl/vdab070.015

Ejemplares similares